-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
September 29, 2015 - In order to further strengthen the coordination and guidance of the investigation and prosecution of cases of illegal production and sale of Ginkgo biloba drugs, the General Administration of Food and Drug Administration held a coordination meeting on the investigation and prosecution of cases of illegal production and sale of Ginkgo biloba drugs in Beijing. Wu Wei, a member of the Party Group of the General Administration, and Guo Wenqi, a member of the Party Group of the General Administration and Director of Food Safety, attended the meeting. The relevant provincial (district, city) Food and Drug Administration responsible for comrades and drug production supervision and inspection departments are mainly responsible for comrades to participate in the meeting.
meeting, the comrades of the Food and Drug Administration of the participating provinces (districts and cities) respectively reported on the progress of the special management of Ginkgo biloba drugs in the region, focusing on the investigation and filing of cases against enterprises suspected of illegal production and sale of Ginkgo biloba extracts and preparations, as well as the specific problems in the investigation and prosecution work, and made recommendations for the next step.the
meeting stressed that the illegal production and sale of Ginkgo biloba extract and its preparations, in violation of the Drug Administration Law and other laws and regulations, the people's drug safety and physical health caused harm, must be resolutely and seriously investigated in accordance with the law; The food and drug regulatory departments should deeply implement the "four most stringent" requirements of the CPC Central Committee and the State Council for the supervision of food and drug products, ascensively ascensive, quasi-determinized, lenient, and punished according to law, so as to ensure that cases are investigated and dealt with in place.
meeting called on food and drug regulatory departments at all levels to do a better job in the illegal production and sale of Ginkgo biloba extracts and preparations cases. First, unified thinking, awareness-raising, in accordance with the "four most stringent" requirements, in accordance with the law to do a good job in the investigation and prosecution of cases. Second, strengthen the organization and leadership of the investigation and prosecution of cases, mainly responsible for comrades to personally organize, urge the guidance of the case handling departments to do a good job in the investigation and prosecution of each case. Third, with strong case handling force, the deployment of capable personnel to form a task force to focus on handling cases, in principle, drug production enterprises illegal cases by the provincial bureau directly open a case for investigation and prosecution, drug business enterprises and use units illegal cases by the municipal bureau directly open a case to investigate and deal with, to ensure that the case is investigated and dealt with in place. Fourth, strengthen the interface with the work of the judicial organs, resolutely transfer cases of suspected crimes to the public security organs in accordance with the law, and prevent punishment and punishment. Fifth, strengthen coordination and cooperation at all levels to improve the efficiency of illegal lead notification and case investigation and response. Sixth, the progress of the investigation and prosecution of cases reported to the General Administration in a timely manner, strengthen coordination up and down, to maintain smooth information. (National Food and Drug Administration)